Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. (Q43646734)

From Wikidata
Jump to navigation Jump to search
scientific article published in June 2001
edit
Language Label Description Also known as
English
Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1.
scientific article published in June 2001

    Statements

    Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. (English)
    F Jänicke
    A Prechtl
    C Thomssen
    N Harbeck
    C Meisner
    C G Sweep
    H K Selbmann
    H Graeff
    M Schmitt
    German N0 Study Group
    1 June 2001
    913-920

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit